Date Filed | Type | Description |
06/26/2017 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/20/2017 |
4
| Butman Bryan T (Senior Vice President) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 4,710 shares
@ $7.19, valued at
$33.9k
Disposed/sold 9,428 shares
@ $0 Exercised 6,000 options to buy
@ $5.6, valued at
$33.6k
|
|
06/20/2017 |
4
| HOCKMEYER WAYNE T (Director) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 793 shares
@ $7.19, valued at
$5.7k
Disposed/sold 8,507 shares
@ $0 Exercised 1,500 options to buy
@ $3.8, valued at
$5.7k
|
|
06/20/2017 |
4
| KELLEY WILLAM N (Director) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 793 shares
@ $7.19, valued at
$5.7k
Disposed/sold 8,257 shares
@ $0 Exercised 1,500 options to buy
@ $3.8, valued at
$5.7k
|
|
06/20/2017 |
4
| Lambert James Vincent (VP, Accounting & Finance) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 3,115 shares
@ $7.19, valued at
$22.4k
Disposed/sold 2,866 shares
@ $0 Exercised 4,000 options to buy
@ $5.6, valued at
$22.4k
|
|
06/20/2017 |
4
| Mallette Quinterol J (Director) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 793 shares
@ $7.19, valued at
$5.7k
Disposed/sold 707 shares
@ $0 Exercised 1,500 options to buy
@ $3.8, valued at
$5.7k
|
|
06/20/2017 |
4
| Richman Michael (Director) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 1,189 shares
@ $7.19, valued at
$8.5k
Disposed/sold 1,061 shares
@ $0 Exercised 2,250 options to buy
@ $3.8, valued at
$8.6k
|
|
06/20/2017 |
4
| Schneebaum Marc R (Director) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 793 shares
@ $7.19, valued at
$5.7k
Disposed/sold 8,257 shares
@ $0 Exercised 1,500 options to buy
@ $3.8, valued at
$5.7k
|
|
06/20/2017 |
4
| Swirsky Douglas J (President and CEO) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 20,930 shares
@ $7.19, valued at
$150.5k
Disposed/sold 29,320 shares
@ $0 Exercised 25,000 options to buy
@ $5.6, valued at
$140k
|
|
06/20/2017 |
4
| Loren Stefan (Director) has filed a Form 4 on GENVEC INC
Txns:
| Paid exercise price by delivering 793 shares
@ $7.19, valued at
$5.7k
Disposed/sold 1,207 shares
@ $0 Exercised 1,500 options to buy
@ $3.8, valued at
$5.7k
|
|
06/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/16/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/16/2017 |
RW
| Form RW - Registration Withdrawal Request |
06/16/2017 |
8-K
| Quarterly results |
06/16/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
06/15/2017 |
8-K
| Form 8-K - Current report |
05/17/2017 |
8-K
| Form 8-K - Current report |
05/12/2017 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
05/10/2017 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/14/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
03/06/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
02/16/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/14/2017 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 0% stake in GenVec, Inc. |
02/14/2017 |
SC 13G/A
| Anson Funds Management LP reports a 0.5% stake in GenVec, Inc. |
02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/08/2017 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.3% stake in GenVec, Inc. |
01/31/2017 |
SC 13G
| Aristides Capital LLC reports a 7.5% stake in GenVec, Inc. |
|